Significant modulation of mitochondrial electron transport system by nicotine in various rat brain regions

Mitochondrion

Volumn 9, Issue 3, 2009, Pages 186-195

  Wang, Ju ^a   Kim, Jong Man ^a   Donovan, David M ^b   Becker, Kevin G ^c   Li, Ming D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Brain; Gene expression; Microarray; Mitochondria; Nicotine

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME B; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE I; CYTOCHROME C OXIDASE II; CYTOCHROME C OXIDASE III; DOPAMINE; NICOTINE; PROTEIN SUBUNIT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; UNCLASSIFIED DRUG; GANGLION STIMULATING AGENT;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE EXPRESSION PROFILING; HIPPOCAMPUS; MITOCHONDRIAL ENERGY TRANSFER; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM; ANIMAL; BRAIN; DNA MICROARRAY; DRUG EFFECTS; ELECTRON TRANSPORT; MITOCHONDRION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; ELECTRON TRANSPORT; FEMALE; GANGLIONIC STIMULANTS; GENE EXPRESSION PROFILING; MITOCHONDRIA; NICOTINE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 64549103371     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2009.01.008     Document Type: Article

References (76)

1. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., and Sherlock G. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25 (2000) 25-29
2. Aydos K., Guven M.C., Can B., and Ergun A. Nicotine toxicity to the ultrastructure of the testis in rats. BJU Int. 88 (2001) 622-626
3. Barbieri R.L., Friedman A.J., and Osathanondh R. Cotinine and nicotine inhibit human fetal adrenal 11 beta-hydroxylase. J. Clin. Endocrinol. Metab. 69 (1989) 1221-1224
4. Barik J., and Wonnacott S. Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal. Mol. Pharmacol. 69 (2006) 618-628
5. Barrett T., Xie T., Piao Y., Dillon-Carter O., Kargul G.J., Lim M.K., et al. A murine dopamine neuron-specific cDNA library and microarray: increased COX1 expression during methamphetamine neurotoxicity. Neurobiol. Dis. 8 (2001) 822-833
6. Bhagwat S.V., Vijayasarathy C., Raza H., Mullick J., and Avadhani N.G. Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain. Biochem. Pharmacol. 56 (1998) 831-839
7. Blakely E.L., Mitchell A.L., Fisher N., Meunier B., Nijtmans L.G., Schaefer A.M., Jackson M.J., Turnbull D.M., and Taylor R.W. A mitochondrial cytochrome b mutation causing severe respiratory chain enzyme deficiency in humans and yeast. FEBs J. 272 (2005) 3583-3592
8. Bruin J.E., Gerstein H.C., Morrison K.M., and Holloway A.C. Increased pancreatic beta-cell apoptosis following fetal and neonatal exposure to nicotine is mediated via the mitochondria. Toxicol. Sci. 103 (2008) 362-370
9. Bruin J.E., Petre M.A., Lehman M.A., Raha S., Gerstein H.C., Morrison K.M., and Holloway A.C. Maternal nicotine exposure increases oxidative stress in the offspring. Free Radical Bio. Med. 44 (2008) 1919-1925
10. Bruin J.E., Petre M.A., Raha S., Morrison K.M., Gerstein H.C., and Holloway A.C. Fetal and neonatal nicotine exposure in Wistar rats causes progressive pancreatic mitochondrial damage and beta cell dysfunction. PLoS ONE 3 (2008) e3371
11. Budde S.M., van den Heuvel L.P., Janssen A.J., Smeets R.J., Buskens C.A., DeMeirleir L., Van Coster R., Baethmann M., Voit T., Trijbels J.M., and Smeitink J.A. Combined enzymatic complex I and III deficiency associated with mutations in the nuclear encoded NDUFS4 gene. Biochem. Biophys. Res. Commun. 275 (2000) 63-68
12. Cormier A., Morin C., Zini R., Tillement J.P., and Lagrue G. In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation. Brain Res. 900 (2001) 72-79
13. Cormier A., Morin C., Zini R., Tillement J.P., and Lagrue G. Nicotine protects rat brain mitochondria against experimental injuries. Neuropharmacology 44 (2003) 642-652
14. Crowley-Weber C.L., Dvorakova K., Crowley C., Bernstein H., Bernstein C., Garewal H., and Payne C.M. Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem. Biol. Interact. 145 (2003) 53-66
15. Cucina A., Sapienza P., Borrelli V., Corvino V., Foresi G., Randone B., et al. Nicotine reorganizes cytoskeleton of vascular endothelial cell through platelet-derived growth factor BB. J. Surg. Res. 92 (2000) 233-238
16. Dajas-Bailador F., and Wonnacott S. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 25 (2004) 317-324
17. Dani J.A., and Harris R.A. Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat. Neurosci. 8 (2005) 1465-1470
18. Dasgupta P., and Chellappan S.P. Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle 5 (2006) 2324-2328
19. Dasgupta P., Rastogi S., Pillai S., Ordonez-Ercan D., Morris M., Haura E., and Chellappan S. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J. Clin. Invest. 116 (2006) 2208-2217
20. Dumoulin R., Sagnol I., Ferlin T., Bozon D., Stepien G., and Mousson B. A novel gly290asp mitochondrial cytochrome b mutation linked to a complex III deficiency in progressive exercise intolerance. Mol. Cell. Probe. 10 (1996) 389-391
21. Galvin R.J., Ramp W.K., and Lenz L.G. Smokeless tobacco contains a nonnicotine inhibitor of bone metabolism. Toxicol. Appl. Pharmacol. 95 (1988) 292-300
22. Grazina M., Pratas J., Silva F., Oliveira S., Santana I., and Oliveira C. Genetic basis of Alzheimer's dementia: role of mtDNA mutations. Genes Brain Behav. 5 Suppl. 2 (2006) 92-107
23. Gutala R., Wang J., Kadapakkam S., Hwang Y., Ticku M., and Li M.D. Microarray analysis of ethanol-treated cortical neurons reveals disruption of genes related to the ubiquitin-proteasome pathway and protein synthesis. Alcohol Clin. Exp. Res. 28 (2004) 1779-1788
24. 2+. Biochem. J. 244 (1987) 159-164
25. Halestrap A.P. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim. Biophys. Acta 973 (1989) 355-382
26. Harkness P.C., and Millar N.S. Changes in conformation and subcellular distribution of alpha4beta2 nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimeras. J. Neurosci. 22 (2002) 10172-10181
27. Huttemann M., Lee I., Samavati L., Yu H., and Doan J.W. Regulation of mitochondrial oxidative phosphorylation through cell signaling. Biochim. Biophys. Acta 1773 (2007) 1701-1720
28. Hwang Y.Y., and Li M.D. Proteins differentially expressed in response to nicotine in five rat brain regions: identification using a 2-DE/MS-based proteomics approach. Proteomics 6 (2006) 3138-3153
29. Ichino N., Ishiguro H., Yamada K., Nishii K., Sawada H., and Nagatsu T. Nicotine withdrawal up-regulates c-Fos transcription in pheochromocytoma cells. Neurosci. Res. 35 (1999) 63-69
30. Ichino N., Yamada K., Nishii K., Sawada H., Nagatsu T., and Ishiguro H. Increase of transcriptional levels of egr-1 and nur77 genes due to both nicotine treatment and withdrawal in pheochromocytoma cells. J. Neural. Transm. 109 (2002) 1015-1022
31. Jin Z., and Roomans G.M. Effects of nicotine on the uterine epithelium studied by X-ray microanalysis. J. Submicrosc. Cytol. Pathol. 29 (1997) 179-186
32. Kane J.K., Konu O., Ma J.Z., and Li M.D. Nicotine coregulates multiple pathways involved in protein modification/degradation in rat brain. Brain Res. Mol. Brain Res. 132 (2004) 181-191
33. Katyare S.S., and Shallom J.M. Altered cerebral protein turnover in rats following prolonged in vivo treatment with nicotine. J. Neurochem. 50 (1988) 1356-1363
34. Konu O., Kane J.K., Barrett T., Vawter M.P., Chang R., Ma J.Z., Donovan D.M., Sharp B., Becker K.G., and Li M.D. Region-specific transcriptional response to chronic nicotine in rat brain. Brain Res. 909 (2001) 194-203
35. Konu O., Xu X., Ma J.Z., Kane J., Wang J., Shi S.J., and Li M.D. Application of a customized pathway-focused microarray for gene expression profiling of cellular homeostasis upon exposure to nicotine in PC12 cells. Brain Res. Mol. Brain Res. 121 (2004) 102-113
36. Lahmouzi J., Simain-Sato F., Defresne M.P., De Pauw M.C., Heinen E., Grisar T., Legros J.J., and Legrand R. Effect of nicotine on rat gingival fibroblasts in vitro. Connect. Tissue Res. 41 (2000) 69-80
37. Landais E., El-Khoury V., Prevost A., Dufer J., and Liautaud-Roger F. Nicotine induces chromatin changes and c-Jun up-regulation in HL-60 leukemia cells. Oncol. Rep. 14 (2005) 1553-1558
38. Legros F., Chatzoglou E., Frachon P., Ogier De Baulny H., Laforet P., Jardel C., Godinot C., and Lombes A. Functional characterization of novel mutations in the human cytochrome b gene. Eur. J. Hum. Genet. 9 (2001) 510-518
39. Li M.D., Kane J.K., Wang J., and Ma J.Z. Time-dependent changes in transcriptional profiles within five rat brain regions in response to nicotine treatment. Brain Res. Mol. Brain Res. 132 (2004) 168-180
40. Lim K.H., Javadov S.A., Das M., Clarke S.J., Suleiman M.S., and Halestrap A.P. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J. Physiol. 545 (2002) 961-974
41. Lin M.T., and Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006) 787-795
42. MacDermott A.B., Role L.W., and Siegelbaum S.A. Presynaptic ionotropic receptors and the control of transmitter release. Annu. Rev. Neurosci. 22 (1999) 443-485
43. Malin D.H. Nicotine dependence. Studies with a laboratory model. Pharmacol. Biochem. Behav. 70 (2001) 551-559
44. Maritz G.S., and Thomas R.A. The influence of maternal nicotine exposure on the interalveolar septal status of neonatal rat lung. Cell Biol. Int. 18 (1994) 747-757
45. McKay B.E., Placzek A.N., and Dani J.A. Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors. Biochem. Pharmacol. 74 (2007) 1120-1133
46. Obata T., Aomine M., Inada T., and Kinemuchi H. Nicotine suppresses 1-methyl-4-phenylpyridinium ion-induced hydroxyl radical generation in rat striatum. Neurosci. Lett. 330 (2002) 122-124
47. Onal A., Uysal A., Ulker S., Delen Y., Yurtseven M.E., and Evinc A. Alterations of brain tissue in fetal rats exposed to nicotine in utero: possible involvement of nitric oxide and catecholamines. Neurotoxicol. Teratol. 26 (2004) 103-112
48. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. xxvi ed. (1998), Academic Press, Sydney 237 pp
49. Picciotto M.R., and Zoli M. Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Front. Biosci. 13 (2008) 492-504
50. Pontieri F.E., Tanda G., Orzi F., and Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382 (1996) 255-257
51. Qiu X., Chen Y., and Zhou M. Two point mutations in mitochondrial DNA of cytochrome c oxidase coexist with normal mtDNA in a patient with Alzheimer's disease. Brain Res. 893 (2001) 261-263
52. Quik M. Smoking, nicotine and Parkinson's disease. Trends Neurosci. 27 (2004) 561-568
53. Rana M., de Coo I., Diaz F., Smeets H., and Moraes C.T. An out-of-frame cytochrome b gene deletion from a patient with Parkinsonism is associated with impaired complex III assembly and an increase in free radical production. Ann. Neurol. 48 (2000) 774-781
54. Rego A.C., and Oliveira C.R. Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem. Res. 28 (2003) 1563-1574
55. Rimessi A., Giorgi C., Pinton P., and Rizzuto R. The versatility of mitochondrial calcium signals: from stimulation of cell metabolism to induction of cell death. Biochim. Biophys. Acta 1777 (2008) 808-816
56. Robbins T.W., and Everitt B.J. Drug addiction: bad habits add up. Nature 398 (1999) 567-570
57. Robinson T.E., and Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47 Suppl. 1 (2004) 33-46
58. Roy T.S., and Sabherwal U. Effects of gestational nicotine exposure on hippocampal morphology. Neurotoxicol. Teratol. 20 (1998) 465-473
59. Sallette J., Pons S., Devillers-Thiery A., Soudant M., Prado de Carvalho L., Changeux J.P., and Corringer P.J. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46 (2005) 595-607
60. Salvi M., Brunati A.M., and Toninello A. Tyrosine phosphorylation in mitochondria: a new frontier in mitochondrial signaling. Free Radical Biol. Med. 38 (2005) 1267-1277
61. * nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse 38 (2000) 375-383
62. Shim I., Javaid J.I., Wirtshafter D., Jang S.Y., Shin K.H., Lee H.J., Chung Y.C., and Chun B.G. Nicotine-induced behavioral sensitization is associated with extracellular dopamine release and expression of c-Fos in the striatum and nucleus accumbens of the rat. Behav. Brain Res. 121 (2001) 137-147
63. Soto-Otero R., Mendez-Alvarez E., Hermida-Ameijeiras A., Lopez-Real A.M., and Labandeira-Garcia J.L. Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease. Biochem. Pharmacol. 64 (2002) 125-135
64. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., and Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005) 15545-15550
65. 2+ signaling. Physiology (Bethesda) 23 (2008) 84-94
66. Tang K., Wu H., Mahata S.K., and O'Connor D.T. A crucial role for the mitogen-activated protein kinase pathway in nicotinic cholinergic signaling to secretory protein transcription in pheochromocytoma cells. Mol. Pharmacol. 54 (1998) 59-69
67. Turegano L., Martinez-Rodriguez R., Alvarez M.I., Gragera R.R., Gomez de Segura A., De Miguel E., et al. Histochemical study of acute and chronic intraperitoneal nicotine effects on several glycolytic and Krebs cycle dehydrogenase activities in the frontoparietal cortex and subcortical nuclei of the rat brain. J. Neurosci. Res. 64 (2001) 626-635
68. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98 (2001) 5116-5121
69. Vizi E.S., and Lendvai B. Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res. Brain Res. Rev. 30 (1999) 219-235
70. Winer J., Jung C.K., Shackel I., and Williams P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270 (1999) 41-49
71. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20 (1997) 92-98
72. Wonnacott S., Sidhpura N., and Balfour D.J. Nicotine: from molecular mechanisms to behaviour. Curr. Opin. Pharmacol. 5 (2005) 53-59
73. Xie Y.X., Bezard E., and Zhao B.L. Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria. J. Biol. Chem. 280 (2005) 32405-32412
74. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., and Speed T.P. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30 (2002) e15
75. Zhang J., Kamdar O., Le W., Rosen G., and Upadhyay D. Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am. J. Resp. Cell Mol. Biol. (2008)
76. Zimmerman M., and McGeachie J. The effect of nicotine on aortic endothelium. A quantitative ultrastructural study. Atherosclerosis 63 (1987) 33-41